| __timestamp | Takeda Pharmaceutical Company Limited | Verona Pharma plc |
|---|---|---|
| Wednesday, January 1, 2014 | 382096000000 | 4101058 |
| Thursday, January 1, 2015 | 345927000000 | 10763215 |
| Friday, January 1, 2016 | 312303000000 | 5579049 |
| Sunday, January 1, 2017 | 325441000000 | 32051299 |
| Monday, January 1, 2018 | 368298000000 | 24482286 |
| Tuesday, January 1, 2019 | 492381000000 | 43892589 |
| Wednesday, January 1, 2020 | 455833000000 | 44505000 |
| Friday, January 1, 2021 | 526087000000 | 79406000 |
| Saturday, January 1, 2022 | 633325000000 | 49283000 |
| Sunday, January 1, 2023 | 729924000000 | 17282730 |
| Monday, January 1, 2024 | 729924000000 |
Unleashing insights
In the competitive world of pharmaceuticals, innovation is key. Takeda Pharmaceutical Company Limited and Verona Pharma plc are two companies that have taken different paths in their investment strategies. Over the past decade, Takeda has consistently outpaced Verona in research and development (R&D) spending. In 2023, Takeda's R&D expenses were approximately 17,800 times greater than Verona's, highlighting a significant commitment to innovation. Takeda's investment has grown steadily, with a notable increase of around 91% from 2014 to 2023. In contrast, Verona's R&D spending peaked in 2021 but has since declined. This disparity underscores Takeda's robust strategy in driving pharmaceutical advancements. As we look to the future, the question remains: will Verona increase its investment to compete, or will Takeda continue to lead the charge in pharmaceutical innovation?
R&D Insights: How Johnson & Johnson and Verona Pharma plc Allocate Funds
Research and Development Expenses Breakdown: Pfizer Inc. vs Takeda Pharmaceutical Company Limited
R&D Insights: How Amgen Inc. and Verona Pharma plc Allocate Funds
Research and Development: Comparing Key Metrics for Sanofi and Takeda Pharmaceutical Company Limited
Research and Development Expenses Breakdown: Takeda Pharmaceutical Company Limited vs BioMarin Pharmaceutical Inc.
Research and Development Expenses Breakdown: Takeda Pharmaceutical Company Limited vs Sarepta Therapeutics, Inc.
Takeda Pharmaceutical Company Limited vs Amphastar Pharmaceuticals, Inc.: Strategic Focus on R&D Spending
Comparing Innovation Spending: Takeda Pharmaceutical Company Limited and Xencor, Inc.
Corcept Therapeutics Incorporated or Verona Pharma plc: Who Invests More in Innovation?
Verona Pharma plc vs Amneal Pharmaceuticals, Inc.: Strategic Focus on R&D Spending
Verona Pharma plc vs Iovance Biotherapeutics, Inc.: Strategic Focus on R&D Spending
Research and Development Expenses Breakdown: Verona Pharma plc vs MiMedx Group, Inc.